Literature DB >> 26645459

Update on Thin Melanoma: Outcome of an International Workshop.

Daniela Mihic-Probst1, Chris Shea, Lyn Duncan, Arnaud de la Fouchardiere, Gilles Landman, Jennifer Landsberg, Joost ven den Oord, Lori Lowe, Martin G Cook, Sook Jung Yun, Loren Clarke, Jane Messina, David E Elder, Raymond L Barnhill.   

Abstract

The following communication summarizes the proceedings of a 1-day Workshop of the International Melanoma Pathology Study Group, which was devoted to thin melanoma. The definitions and histologic criteria for thin melanoma were reviewed. The principal differential diagnostic problems mentioned included the distinction of thin melanoma from nevi, especially from nevi of special site, irritated nevi, inflamed and regressing nevi, and dysplastic nevi. Histologic criteria for this analysis were discussed and the importance of clinico-pathologic correlation, especially in acral sites, was emphasized. Criteria for the minimal definition of invasion were also discussed. In addition, a new technique of m-RNA expression profiling with 14 genes was presented and facilitated the distinction of thin melanomas from nevus in histologically obvious cases. However, for particular nevi, it was not obvious why the results indicated a malignant lesion. Despite many molecular and other ancillary investigations, Breslow thickness remains the most important prognostic factor in thin melanoma. The prognostic significance of radial (horizontal) and vertical growth phases, Clark level, regression, and mitotic rate were also discussed. Because of the increasing frequency of thin melanomas, there is a great need to develop more refined predictors of thin melanomas with worse clinical outcome.

Entities:  

Mesh:

Year:  2016        PMID: 26645459     DOI: 10.1097/PAP.0000000000000100

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  7 in total

1.  Using global gene expression to discriminate thin melanomas with poor outcomes.

Authors:  Zachary Hothem; Andrew Bayci; Bryan J Thibodeau; Billie E Ketelsen; Laura E Fortier; Alison F Uzieblo; Diane Cosner; Kristin Totoraitis; Richard D Keidan; George D Wilson
Journal:  Mol Cell Oncol       Date:  2016-11-08

2.  The significance of regression in thin melanoma of the skin.

Authors:  L Roncati; F Piscioli; T Pusiol
Journal:  Ir J Med Sci       Date:  2017-04-28       Impact factor: 1.568

3.  Lymphatic invasion and angiotropism in primary cutaneous melanoma.

Authors:  Andrea P Moy; Lyn M Duncan; Stefan Kraft
Journal:  Lab Invest       Date:  2016-12-19       Impact factor: 5.662

4.  Mitotic rate is associated with positive lymph nodes in patients with thin melanomas.

Authors:  Lee Wheless; Chelsea A Isom; Mary A Hooks; Rondi M Kauffmann
Journal:  J Am Acad Dermatol       Date:  2017-12-01       Impact factor: 11.527

5.  Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients.

Authors:  D Zugna; R Senetta; S Osella-Abate; M T Fierro; A Pisacane; A Zaccagna; A Sapino; V Bataille; A Maurichi; F Picciotto; P Cassoni; P Quaglino; S Ribero
Journal:  Br J Cancer       Date:  2017-11-09       Impact factor: 7.640

6.  BRAFV600E and KIT immunoexpression in early-stage melanoma.

Authors:  Andressa Germano; Leonardo Cardili; Fernando Cintra Lopes Carapeto; Gilles Landman
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

7.  Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile.

Authors:  Antonio G Richetta; Virginia Valentini; Federica Marraffa; Giovanni Paolino; Piera Rizzolo; Valentina Silvestri; Veronica Zelli; Anna Carbone; Cinzia Di Mattia; Stefano Calvieri; Pasquale Frascione; Pietro Donati; Laura Ottini
Journal:  Oncotarget       Date:  2018-08-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.